Li et al. found that puerarin may reduce activation hepatic stellate cell and alleviate extracellular matrix protein expression levels by inhibiting the TGF-β/ERK1/2 pathway in liver fibrosis (Li et al., 2019). Here, MAPK3 is linked to Hepatic fibrosis.